Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1301, doi. 10.1080/14656566.2017.1365837
- By:
- Publication type:
- Article
Works in Expert Opinion on Pharmacotherapy, 2017, Vol 18, Issue 13
Results: 14
1
2
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1357, doi. 10.1080/14656566.2017.1363181
- By:
- Publication type:
- Article
3
New treatment options for lower respiratory tract infections.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1345, doi. 10.1080/14656566.2017.1363179
- By:
- Publication type:
- Article
4
Pharmacotherapy of glaucoma: new opportunities, old challenges.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
5
Small molecules as therapy for uveitis: a selected perspective of new and developing agents.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1311, doi. 10.1080/14656566.2017.1361408
- By:
- Publication type:
- Article
6
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD).
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1333, doi. 10.1080/14656566.2017.1361407
- By:
- Publication type:
- Article
7
The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1409, doi. 10.1080/14656566.2017.1361406
- By:
- Publication type:
- Article
8
Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1325, doi. 10.1080/14656566.2017.1361405
- By:
- Publication type:
- Article
9
Evaluation of brivaracetam: a new drug to treat epilepsy.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1381, doi. 10.1080/14656566.2017.1359260
- By:
- Publication type:
- Article
10
Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1291, doi. 10.1080/14656566.2017.1359259
- By:
- Publication type:
- Article
11
Efficacy of elagolix in the treatment of endometriosis.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1391, doi. 10.1080/14656566.2017.1359258
- By:
- Publication type:
- Article
12
Agomelatine for the treatment of generalized anxiety disorder.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1373, doi. 10.1080/14656566.2017.1359257
- By:
- Publication type:
- Article
13
Efficacy of baricitinib in the treatment of rheumatoid arthritis.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1399, doi. 10.1080/14656566.2017.1359256
- By:
- Publication type:
- Article
14
Ataluren in cystic fibrosis: development, clinical studies and where are we now?
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1363, doi. 10.1080/14656566.2017.1359255
- By:
- Publication type:
- Article